BACKGROUND: Perspectives of clinical trial (CT) personnel on accrual to oncology CTs are relatively absent from the literature. This study explores CT personnels experience recruiting patients to oncology CTs. METHODS: A qualitative study design was utilized. In-depth, individual interviews with 12 oncology CT personnel were conducted, including six CT nurses and six physician-investigators. Interviews were digitally recorded and transcribed verbatim. Data were subjected to thematic and ethical analysis to identify key concepts and themes. RESULTS: CT personnel reported considering two ethical commitments in CT recruitment: maintaining trial integrity and ensuring patient autonomy through obtaining informed consent. The process of gatekeepi...
Clinical cancer trials in the 21st century take place only with the ethics review committee’s approv...
Background: Recruitment of patients into randomised clinical trials (RCTs) is essential for treatmen...
[[abstract]]BACKGROUND: Clinical trials provide information for developing new treatment strategies,...
In the United States, 1.2 million Americans are diagnosed with cancer annually and only 2.5% of adul...
Randomised clinical trials have come to be regarded as the gold standard in treatment evaluation. Ho...
Recruitment processes for clinical trials are governed by guidelines and regulatory systems intended...
Accrual to clinical trials continues to be a problem in many countries including Australia despite i...
Clinical trials are necessary for the advancement of cancer treatment and care, however low rates of...
Clinical trials (CTs) in cancer care play an essential role in advancing knowledge and improving pat...
BACKGROUND: Clinical cancer trials are crucial for the implementation of new treatments in the clini...
Context: With the routinization of evidence-based medicine and of the randomized-controlled trial (R...
Background: Research governance requires patients give informed consent to participate in clinical t...
Introduction: Prospective clinical trials are essential to translate new therapy concepts or rather ...
Patient recruitments are a crucial part of clinical research, especially in the medical oncology fie...
Clinical cancer trials in the 21st century take place only with the ethics review committee’s approv...
Background: Recruitment of patients into randomised clinical trials (RCTs) is essential for treatmen...
[[abstract]]BACKGROUND: Clinical trials provide information for developing new treatment strategies,...
In the United States, 1.2 million Americans are diagnosed with cancer annually and only 2.5% of adul...
Randomised clinical trials have come to be regarded as the gold standard in treatment evaluation. Ho...
Recruitment processes for clinical trials are governed by guidelines and regulatory systems intended...
Accrual to clinical trials continues to be a problem in many countries including Australia despite i...
Clinical trials are necessary for the advancement of cancer treatment and care, however low rates of...
Clinical trials (CTs) in cancer care play an essential role in advancing knowledge and improving pat...
BACKGROUND: Clinical cancer trials are crucial for the implementation of new treatments in the clini...
Context: With the routinization of evidence-based medicine and of the randomized-controlled trial (R...
Background: Research governance requires patients give informed consent to participate in clinical t...
Introduction: Prospective clinical trials are essential to translate new therapy concepts or rather ...
Patient recruitments are a crucial part of clinical research, especially in the medical oncology fie...
Clinical cancer trials in the 21st century take place only with the ethics review committee’s approv...
Background: Recruitment of patients into randomised clinical trials (RCTs) is essential for treatmen...
[[abstract]]BACKGROUND: Clinical trials provide information for developing new treatment strategies,...